Skip to content Skip to footer

Innovent and Ascentage Pharma Reach Multifaceted Strategic Agreement including Joint Commercialization of Olverembatinib in China, Joint Clinical Development on Multiple Products, and Equity Investment

Langgan

Surat Berita

订阅我们的月讯

Subscribe to our

Newsletter